{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:34:18Z","timestamp":1791164058221,"version":"4.1.0"},"reference-count":7,"publisher":"BMJ","issue":"6255","license":[{"start":{"date-parts":[[1980,12,13]],"date-time":"1980-12-13T00:00:00Z","timestamp":345513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J"],"published-print":{"date-parts":[[1980,12,13]]},"abstract":"<jats:p>In a trial of postoperative adjuvant chemotherapy women with primary breast cancer and spread to one or more axillary nodes were randomised to receive a six-month course of either the single agent chlorambucil or the five-drug combination of chlorambucil, methotrexate, fluorouracil, vincristine, and adriamycin. On completing the treatment 47 patients were asked to fill in questionnaires at home on the side effects of treatment and its influence on the quality of their life. Side effects including nausea, vomiting, malaise, and alopecia had been severe enough to interfere with their lifestyle in 9 (42%) of the patients who had received the single agent and 19 (79%) of those who had received multiple-drug treatment. Various other side effects were reported by a few patients. Seven (29%) of the patients who had received the multiple-drug schedule voluntarily added that the treatment had been \"unbearable\" or \"could never be gone though again.\" The proportion of patients who had experienced severe side effects while receiving the treatment was considerable; hence such adjuvant chemotherapy is justifiable only if it will substantially improve a patient's prognosis.<\/jats:p>","DOI":"10.1136\/bmj.281.6255.1594","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T18:32:30Z","timestamp":1238697150000},"page":"1594-1597","source":"Crossref","is-referenced-by-count":73,"title":["Adjuvant chemotherapy for breast cancer: side effects and quality of life."],"prefix":"10.1136","volume":"281","author":[{"given":"B V","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G A","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"McKinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W P","family":"Greening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1980,12,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJM197501162920301","article-title":"L-Phenylalanine mustard (L-Pam) in the management of primary breast cancer","volume":"292","author":"Fisher, B.; Carbone, P.; Economou, S.G.","year":"1975","unstructured":"Fisher B, Carbone P, Economou SG, et al. L-Phenylalanine mustard (L-Pam) in the management of primary breast cancer. N Engl J Med 1975;292:117-22.","journal-title":"N Engl J Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1056\/NEJM197602192940801","article-title":"Combination chemotherapy as an adjuvant treatment in operable cancer","volume":"294","author":"Bonadonna, G.; Brusamolino, E.; Valagussa, P.","year":"1976","unstructured":"Bonadonna G, Brusamolino E, Valagussa P, et al. Combination chemotherapy as an adjuvant treatment in operable cancer. N Engl J Med 1976;294:405.","journal-title":"N Engl J Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJM197602192940809","article-title":"Major advance in breast cancer therapy","volume":"294","author":"Anonymous","year":"1976","unstructured":"Anonymous. Major advance in breast cancer therapy. N Engl J Med 1976;294:440.","journal-title":"N Engl J Med"},{"key":"ref_4","first-page":"263","article-title":"Treating breast cancer-true light or false dawn?","volume":"ii:","author":"Anonymous","year":"1976","unstructured":"Anonymous. Treating breast cancer-true light or false dawn? Br Med J 1976;ii:263.","journal-title":"Br Med J"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1002\/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO;2-8","article-title":"The CMF program for operable breast cancer with positive axillary nodes: updated analysis on the disease-free interval, site of relapse and drug tolerance","volume":"39","author":"Bonadonna, G.; Rossi, A.; Valagussa, P.","year":"1977","unstructured":"Bonadonna G, Rossi A, Valagussa P, et al. The CMF program for operable breast cancer with positive axillary nodes: updated analysis on the disease-free interval, site of relapse and drug tolerance. Cancer 1977;39:2904-15.","journal-title":"Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/1097-0142(197706)39:6<2883::AID-CNCR2820390676>3.0.CO;2-9","article-title":"L-Phenylalanine mustard (L-Pam) in the management of primary breast cancer: an update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)","volume":"39","author":"Fisher, B.; Glass, A.; Redmond, C.","year":"1977","unstructured":"Fisher B, Glass A, Redmond C, et al. L-Phenylalanine mustard (L-Pam) in the management of primary breast cancer: an update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU). Cancer 1977;39:2883-3903.","journal-title":"Cancer"},{"key":"ref_7","article-title":"Accepted","year":"1980","unstructured":"(Accepted 22 October 1980)"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.281.6255.1594","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.281.6255.1594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T14:46:14Z","timestamp":1765464374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.281.6255.1594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,12,13]]},"references-count":7,"journal-issue":{"issue":"6255","published-online":{"date-parts":[[1980,12,13]]},"published-print":{"date-parts":[[1980,12,13]]}},"alternative-id":["10.1136\/bmj.281.6255.1594"],"URL":"https:\/\/doi.org\/10.1136\/bmj.281.6255.1594","relation":{},"ISSN":["0007-1447","1468-5833"],"issn-type":[{"value":"0007-1447","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1980,12,13]]}}}